Showing results (1-10 of 12) with videos related to
Sort By:
Pageof 2
Toxicologic Pathology|March 1, 1994
Safety assessment programs for U.S. regulatory agencies: a perspective of requirements and complianceR A BendeleImmunopharmacology|July 17, 1999
Derivation of RNA aptamer inhibitors of human complement C5G Biesecker, L Dihel, K Enney, et al.Drug Delivery|November 20, 2015
Anthracycline Efficacy in vitro: Cytotoxicity of Liposomal/Nonliposomal Daunorubicin and Doxorubicin for Multiple Tumor Cell TypesM E Wiles, C Bell, D Landfair, et al.Toxicologic Pathology|January 1, 1993
Hepatocellular proliferation in ibuprofen-treated miceA M Bendele, J F Hulman, S White, et al.Toxicologic Pathology|June 15, 1999
Regulatory decision strategy for entry of a novel biological therapeutic with a clinically unmonitorable toxicity into clinical trials: pre-IND meetings and a case exampleL E Black, A M Bendele, R A Bendele, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|May 1, 1992
Covalent protein modifications and gene expression changes in rodent liver following administration of methapyrilene: a study using two-dimensional electrophoresisN L Anderson, D C Copple, R A Bendele, et al.Cancer Research|December 15, 1992
Carcinogenicity studies of fluoxetine hydrochloride in rats and miceR A Bendele, E R Adams, W P Hoffman, et al.Electrophoresis|January 1, 1993
Comparisons of protein changes in human and rodent hepatocytes induced by the rat-specific carcinogen, methapyrileneF C Richardson, S C Strom, D M Copple, et al.Toxicologic Pathology|December 10, 1999
An evaluation of the toxicities of 2'-fluorouridine and 2'-fluorocytidine-HCl in F344 rats and woodchucks (Marmota monax)F C Richardson, B C Tennant, D J Meyer, et al.Pharmaceutical Research|April 17, 2001
Pharmacokinetics and safety of an anti-vascular endothelial growth factor aptamer (NX1838) following injection into the vitreous humor of rhesus monkeysD W Drolet, J Nelson, C E Tucker, et al.Pageof 2